ABSTRACT
INTRODUCTION
Salmonella enterica is the etiological agent for various diseases spanning from self-limiting diarrhoea to systemic infections like typhoid fever. Global estimates indicate 21 million typhoid cases ever year (Bhutta and Threlfall 2009) and 93 million (Majowicz et al. 2010) non-typhoidal Salmonella diseases, making it a major cause of mortality and morbidity in developing and underdeveloped countries. Salmonella infection is primarily contracted through ingestion of contaminated food or water or due to close contact with infected/carrier individuals (Hornick 1970) . Once ingested, Salmonella can invade the intestinal barrier by infecting M cells and intestinal epithelial cells (Broz, Ohlson and Monack 2012) . Alternatively, luminal bacteria are sampled by dendritic cells (DCs) (Rescigno et al. 2001) . Post colonisation, the bacteria disseminate through the reticuloendothelial system and reside in host macrophages, DCs, polymorphonuclear cells and hepatic cells (Coburn, Grassl and Finlay 2007) . DCs form the nodal point during salmonellosis, as they are pivotal for bacterial colonisation, systemic dissemination and host adaptive immune responses. Notably, among the professional Antigen Presenting Cells, only DCs are capable of activating both naive and primed T cells (Ni and O'Neill 1997) . This makes DCs relevant in both primary and secondary immune responses against any pathogen. In due course of infection, Salmonella manipulates the host by injecting various virulence effectors through the type III secretion system (T3SS) into the host cell. Among all the T3SS, Salmonella pathogenicity island I (SPI-I)-encoded T3SS1 is crucial for host cell invasion (Hernandez et al. 2004) . During its intracellular life, Salmonella survives and proliferates in Salmonella-containing vacuole (SCV), a modified endosome. Salmonella pathogenicity island II (SPI-2)-encoded T3SS2 is crucial for intracellular survival (Waterman and Holden 2003) .
For successful clearance of Salmonella infection, induction of both CD4
+ and CD8 + T-cell responses is necessary (Ravindran and McSorley 2005) . In particular, CD4 + T cells appear to play a vital role in mitigating Salmonella infection as mice compromised in CD4 + T-cell responses show higher organ burden and succumb to the infection faster (Hess et al. 1996) . T-cell receptor (TCR) recognition of antigenic peptide-Major Histocompatibility Complex (MHC) II complexes along with co-stimulatory signals results in the activation of CD4 + T cells. MHC II pathway presents exogenous antigens to CD4 + T cells. Biosynthesis of α and β chains of MHC II molecules occurs in the endoplasmic reticulum (ER). Within ER, α and β chains along with invariant chain (Ii) assemble into a nonomeric (αβIi) 3 complex. These nonomeric complexes are trafficked to the trans-Golgi network and further to the endolysosomal compartment (Roche and Furuta 2015) . Alternatively, these complexes are directly trafficked to the cell surface. Subsequently, from the plasma membrane they are internalised in an AP-2-dependent manner and targeted to the endolysosomal compartment. The Ii chain is degraded in the endolysosomal compartment to form the CLIP peptide. Further, exogenous antigens derived replace the CLIP peptides and the peptide-loaded MHC II complexes are trafficked to the cell surface for presentation to TCRs (Roche and Furuta 2015) . This complex nature of MHC II-mediated antigen processing and presentation provides pathogens a plethora of opportunities to interfere with antigen presentation and escape host adaptive immune responses. The majority of the insight into Salmonella pathogenesis is derived from Salmonella Typhimurium infections in mice. This model mimics systemic typhoid disease in humans. Salmonella infection of murine bone marrow derived DCs (BMDCs) abrogates the capacity of DCs to present antigen to T cells. A previous report has suggested that this reduction of antigen presentation is due to compromised MHC II-dependent antigen processing (Cheminay, Mohlenbrink and Hensel 2005) . In addition, studies on human DCs have shown that S. Typhimurium reduces the cell surface MHC II levels (Mitchell et al. 2004; Lapaque et al. 2009; Van Parys et al. 2012) . However, the mechanism with which S. Typhimurium impairs MHC II-dependent antigen presentation in BMDC is yet unknown. In this study, we elucidate the pathway by which S. Typhimurium reduces MHC II expression and antigen presentation in infected DCs.
MATERIALS AND METHODS

Cell culture, antibodies and primers
BMDCs were cultured as previously described (Cheminay, Mohlenbrink and Hensel 2005) . Briefly, bone marrow from the femurs and tibias were collected aseptically from C57BL/6 mice. Cells were cultured for 6 days in RPMI-1640 containing 10% heat inactivated Fetal Bovine Serum (FBS), 20 ng/ml mouse Granulocyte Monocyte (mGM)-Colony Stimulating Factor (CSF) (Peprotech), 50 μM β-mercaptoethanol, 100 U/ml penicillin and 100 μg/ml streptomycin. Cells were incubated at 5% CO 2 and 37
• C.
After 3 days, mGM-CSF containing media was supplemented. Loosely adherent cells were collected on the sixth day and used for further experiments (Inaba et al. 1992) . DC purity was 65% to 80%. Peripheral blood mononuclear cells were isolated from blood buffy coats using Hisep LSM 1077 (HiMedia). After Phosphate Buffered Saline (PBS) washing and RBC lysis, cells were cultured for 6 days similarly as BMDC culture, except that mGM-CSF was replaced by human Granulocyte Monocyte CSF. Loosely adherent cells were collected on the sixth day and used for further experiments.
Anti-mouse CD11c PE-conjugated (BD Pharmingen (#557401)), anti-human CD1c (BD Pharmingen (#564900)) and anti-human HLA-DR,DP,DQ (BD Pharmingen (#555557)) antibodies were used for flow cytometry experiments. Antimouse IA/IE (BD Pharmingen (#556999)) antibody was used for immunofluorescence microscopy, flow cytometry, immunoprecipitation and immunoblotting. Anti-K48-linked polyubiquitin (CST (#4289S)), anti-K63-linked polyubiquitin (Enzo life science (#BML-PW0600)) and anti-ubiquitin (Novus Biological (#NB300-130)) antibodies were used for immunoblotting and immunofluorescence microscopy.
For qPCR of MHC II forward primer 5 -ACCAATGAGGC TCCTCAAGC-3 , reverse primer 5 -AAGCAGATGAGGGTGTTGGG-3 , MARCH1 forward primer 5 -GACAATGGTGTGCTGGAATGG-3 , reverse primer 5 -CACAAAGATCACACGGTTGTA-3 , β-actin forward primer 5 -CAGCAAGCAGGAGTACGATG-3 , reverse primer 5 -GCAGCTCAGTAACAGTCCG-3 and GAPDH forward primer 5 -GACAACTTTGGCATTGTGGAA-3 , reverse primer 5 -GGATGCAGGGATGATGTTCTG-3 were used.
Bacterial strains and infection
Salmonella Typhimurium 14028 (ATCC) was grown overnight at 37
• C, 160 rpm. DCs were infected with stationary-phase bacterial culture with an MOI 10. To synchronise the infection, tissue culture plates were subjected to centrifugation at 500 × g for 5 min. Cells were washed with PBS and were treated with RMPI-1640 + 10% FBS containing 50 μg/ml gentamicin for 1 h. Subsequently, the gentamicin concentration was reduced to 10 μg/ml and maintained until the cells were harvested. Bafilomycin (50 nM), folimycin (1 μM), chloroquine (15 μM), MG132 (0.5 μM) and leupeptin hemisulfate (10 μM) were added along with RMPI-1640 containing 10% FBS, 10 μg/ml gentamicin and maintained until the cells were harvested.
Flow cytometry and immunofluorescence
Cells were fixed with 3.5% paraformaldehyde (PFA) for 15 min. All staining was performed in the presence of a permeabilising agent, 0.5% saponin (Sigma) dissolved in 2.5% BSA containing PBS unless mentioned otherwise. Flow cytometry analysis was done using BD Canto II, and data analysis was carried out in Denovo platform. Mean fluorescence intensity was calculated in the CD11c-positive population. All immunofluorescence images were obtained using Zeiss LSM 750 and were analysed using the ZEN black 2012 platform. Mander's colocalisation co-efficient was calculated for region of interest.
Quantitative real-time PCR
Analysis of gene expression was cried out using qPCR. Briefly, RNA from DCs was isolated using TRIzol (Takara) as per the manufacture's protocol. mRNA was reverse transcribed to cDNA using oligo (dT)18 primer and Tetro reverse transcriptase (Bioline) as per protocol. The expression profile of desired gene was evaluated using specific primers (as mentioned in Appendix) by qPCR SYBR master Mix (Takara) in Applied Biosystems ViiTM7 Real time PCR instrument.
ELISA
Estimation of IL-10 in conditioned media was performed according to the manufacturer's instructions. Briefly, 96-well ELISA plates (BD Bioscience) were coated overnight with capture antibody (BD Bioscience (#555252)) at 4 • C. Next day, plates were washed with 0.1% tween-20 containing PBS and blocked with 10% FBS for 1 h. Following blocking wells were washed and incubated with 100 μL of test samples (conditioned media) for 2 h at room temperature. Subsequently, plates were washed and incubated with detection antibody and enzyme reagent for 1 h at room temperature. TMB (sigma) was used as a substrate, and reactions were stopped with 2 N H 2 SO 4 . Absorbance was measured at 450 nm wavelength, and a concentration of IL-10 was interpolated from a standard curve.
Immunoprecipitation and immunoblot
For immunoprecipitation, DCs were infected with an MOI 10 as mentioned previously. After 10 h post infection, cells were washed with PBS and were lysed in native lysis buffer containing 1% Nonidet P-40, 20 mM Tris (pH 8), 2 mM EDTA, 150 mM NaCl and protease inhibitors mixture (Roche Diagnostics) for 30 min at 4 • C. Cell debris was removed by centrifugation at 10 000 rpm for 10 min, and supernatant was treated with anti I-A/I-E (clone M5/114.15.2) antibody (BD Bioscience). Antibody-MHC II complexes were immunoprecipitated using Protein G linked Sepharose beads (Sigma). Beads were extensively washed with washing buffer and denatured at 95
• C for 10 min. Denatured precipitates were subjected to SDS-PAGE (12% gel) followed by transfer to 0.45 μ PVDF membrane. The membrane was blocked using 5% skimmed milk in TTBS for 1 h at room temperature. ECL (Bio Vision) was used for detection, and images were captured using ChemiDoc GE healthcare. All the densitometry analyses were performed using Image J platform. For polyubiquitin blots, ubiquitin bands were normalised with the corresponding MHC II band.
MHC II internalisation assay
For internalisation assay, DCs were infected with Salmonella for 25 min. Surface MHC II was labelled with I-A/I-E (clone M5/114.15.2) antibody (BD Bioscience) for 1 h at 4
• C. After labelling, cells were washed with cold PBS to remove any unbound antibody and were treated with RPMI-1640 containing 10% FBS and 10 μg/ml gentamicin and were chased at 37 • C. Cells were harvested and fixed with 3.5% PFA at different time points. After fixation, surface antibody-MHC II complexes were blocked with anti-rat secondary antibody in the absence of saponin. Subsequently, cells were washed with PBS and internalised antibody-MHC II complexes were stained with alexa647 dye conjugated anti-rat secondary antibody in the presence of 0.05% saponin. After staining, cells were washed with PBS and flow cytometry was performed. For immunofluorescence imaging, after the chase period, cells were stained with alexa647 dye conjugated anti-rat secondary antibody in the presence of 0.05% saponin along with anti-Salmonella and anti-K63 linkage-specific antibody.
In vivo infection
Six-week-old male C57BL/6 mice were either infected with 10 7 bacteria or mock infected via oral gavage. The animal experiments were carried out in accordance with the approved guidelines of the institutional animal ethics committee at Indian Institute of Science, Bangalore, India (Registration No: 48/1999/CPCSEA). All the experiments involving the use of animals were performed according to Institutional Animal Ethics Committee approved protocol. Five days post infection, spleens were collected. For splenic DCs, spleens were mechanically disintegrated and RBC lysis was performed. The adherent cell population was fixed with PFA. DCs were gated in a flow cytometer by using DC marker CD11c. MHC II levels were quantified in the splenic DC subpopulation.
Cryosectioning and fluorescence immunohistochemistry
For immunohistochemistry, 5 days post infection, spleens were collected and fixed with 4% PFA. Fixed tissues were embedded in optimal cutting temperature compound and cryosectioning was performed in -20
• C. Cryosections were sequentially stained with anti-Salmonella, anti-MHC II, anti-CD11c antibody and respective secondary antibodies at 4 • C. After staining, images were acquired in a Zeiss LSM 710 microscope.
Comparison of endosomal/lysosomal pH
In order to compare the endosomal/lysosomal pH, infected and control cells were stained with 100 nM Lysotracker green -DND-26 (Life technologies) for 45 min at 37
• C. Cells were washed harvested followed by flow cytometry analysis at 504/511 nm.
Comparison of Salmonella containing vacuole pH and endosome
pH of SCV was analysed according to the previous report (Chakraborty et al. 2014) . Bacterial or ovalbumin were labelled with 20 μM pH rodo red succinimidyl ester (Invitrogen) at 37
• C for 1 h. Bacteria were washed with 0.1 M sodium bicarbonate buffer (pH 8.4) before and after labelling. DCs were infected with labelled bacteria (MOI 10) for 25 min, and non-internalised bacteria were washed away with PBS followed by gentamicin treatment. Cells were washed, and flow cytometry analysis was carried out at 560/585 nm in BD Canto II.
Reactive Oxygen Species (ROS) measurement
Intracellular ROS quantification was performed by 2 ,7 -Dichlorofluorescin diacetate (H 2 DCFDA) (Sigma) staining. Cells were stained with 10 μM H 2 DCFDA at 37
• C in dark. After 20 min, cells were washed with ice-cold PBS and harvested followed by flow cytometry analysis at 495/530 nm in Canto II.
Statistical analysis
Statistical analyses were performed with the GraphPad Prism software. Student's t-test was performed as indicated. The results are expressed as mean ± SD or mean ± SEM. Group sizes, experiment number and P values for each experiment are described in the figure legends.
RESULTS
Salmonella Typhimurium infection mediates downregulation of total MHC II pool in DCs
Salmonella 
Salmonella Typhimurium infection enhances MARCH1-mediated ubiquitination of MHC II
MHC II is a heterodimer of α (33-35 kDa) and β (25-30 kDa) chains, and ubiquitination of lysine 225 present on the cytoplasmic domain of the MHC II β-chain is critical for MHC II degradation. The length of lysine 225 conjugated ubiquitin is a major determinant in MHC II internalisation and degradation (Ma et al. 2012 ). The presence of two different molecular weight bands in the MHC II immunoprecipitate ( Fig. 2A) can be attributed to different ubiquitin chain lengths. In order to examine the ubiquitination status, MHC II immunoprecipitates from infected and control DCs were probed with anti-ubiquitin antibody. Both the populations of MHC II showed conjugated ubiquitin. In contrast with previous reports, MHC II populations corresponding to only two molecular weights were detected in our study. Furthermore, anti-ubiquitin antibody probing detected only two bands and no ubiquitin ladder was detected in the MHC II immunoprecipitate ( Fig. 2A) . The absence of unqbiquitinated MHC II might be due to insufficient resolution of mono and unubiquitinated MHC II.
To address this issue, we have subjected MHC II immunoprecipitate to a 15% SDS-PAGE gel and carried out immunoblot analysis with both MHC II and ubiquitin antibody. Long exposure of the immunoblot shows poly, mono, and un-ubiquitinated MHC II fraction (Fig. S1D, Supporting Information) ; however, the unubiquitinated band lowest molecular weight is not stained by anti-ubiquitinated antibody (Fig. S1E, Supporting Information) .
As the molecular weight of the MHC II β chain is 25-30 kDa, the ∼35 kDa and ∼60 kDa bands might represent monoubiquitinated and quadramer of ubiquitin in β chains, respectively. A recent study has established the role of MHC II ubiquitin length in MHC II endocytosis and lysosomal targeting in DCs (Ma et al. 2012) . In contrast to oligoubiquitinated MHC II, monoubiquitinated MHC II are less efficiently internalised. Therefore, further immunoblot analysis was carried out for the polyubiquitinated MHC II pool (∼60 kDa). We found that Salmonella infection of DCs resulted in ∼2-fold increase in MHC II polyubiquitination compared to control (Fig. 2B ). Immunofluorescence analysis also shows higher colocalisation of ubiquitin with MHC II in infected cells compared to uninfected or PFA-fixed Salmonella-treated samples ( Fig.  2C and D) . The role of polyubiquitination in MHC II internalisation has been previously implicated (Shin et al. 2006) . Following our observation that Salmonella enhances polyubiquitination of MHC II, we next investigated the effect of Salmonella infection on MHC II internalisation. To study the endocytosis of MHC II, surface MHC II was labelled with anti-MHC II antibody for 1 h at 4
• C. After antibody labelling, unbound antibody was removed by PBS wash and cells were chased at 37
• C for the desired time and cells were subsequently fixed with PFA. These DCs contain three subsets of MHC II: (i) surface MHC II-antibody complex, (ii) internalised MHC II-antibody complex and (iii) intracellular free MHC II. Surface MHC II-antibody complexes were blocked using alexa488 conjugated secondary antibody. For staining of internalised MHC II-antibody complexes, cells were treated with the pore-forming agent, saponin. Pores formed on the cell membrane allowed alexa647 conjugated secondary antibody to stain internalised MHC II-antibody complexes. Hence, the alexa647 intensity is a direct indication of internalised MHC II-antibody complexes and alexa488 intensity indicates surface MHC II. In our study, infected cells show ∼2.4-fold and ∼4-fold higher internalisation of MHC II compared to uninfected and PFA killed bacteria-treated sample, respectively ( Fig. 2E and F) . Concomitantly, we also observe a decrease in un-internalised surface MHC II in STM-infected cells as compared to control ( Fig. 2G and  H) . Thus, the Salmonella-mediated increase in polyubiquitination of MHC II correlates with its enhanced internalisation MHC II in DCs.
Enhanced ubiquitination requires increased levels of E3 ubiquitin ligase activity. In BMDCs, MHC II ubiquitination is largely performed by membrane associated RING-CH (MARCH) 1, an E3 ubiquitin ligase (Cho et al. 2015) . It is a short-lived protein with a half-life of <30 min. During activation of DCs, transcription of MARCH1 is suppressed, resulting in decreased ubiquitination of MHC II (Jabbour et al. 2009 ). In this study, q-PCR analysis of MARCH1 gene showed a biphasic transcriptional regulation. Compared to control cells, infected DCs showed upregulation of MARCH1 expression till 6 h post infection. However, at 20 h post infection, the levels were not different from uninfected control. Notably, treatment with lipopolysaccharide, an activation signal, resulted in downregulation of MARCH1 expression (Fig. 2I) . Thus, it follows that Salmonella infection enhances polyubiquitination of the total MHCII pool by upregulating MARCH 1 expression. Previous study has emphasised on the role of IL-10 in DC maturation and MHC II expression (de Waal Malefyt et al. 1991) . The ability of IL-10 to upregulate MARCH1 expression is previously reported in murine DCs (Tze et al. 2011) and human monocytes ). Pathogens such as murine cytomegalovirus affect MHC II expression in infected cells via enhancing IL-10 expression in infected cells (Redpath et al. 1999) . Thus, we have investigated whether MARCH1 regulation correlates with secreted IL-10 profile in infected cells. Indeed, ELISA of conditioned media confirms our hypothesis that IL-10 levels in cell supernatant are upregulated at 2 h and 6 h as compared to uninfected control (Fig. 2J ). This result might indicate towards the role of IL-10 in MARCH1-dependent downregulation of MHC II.
Salmonella infection enhances lysine 63-linked ubiquitination of MHC II
The interubiquitin linkage in polymeric ubiquitin chains plays a pivotal role in determining the fate of ubiquitinated proteins. Lysine 48-linked ubiquitin-tagged proteins are generally subjected to proteasomal degradation and lysine 63-linked ubiquitintagged proteins are targeted for cellular trafficking (Zinngrebe et al. 2014) . To address the fate of ubiquitinated MHC II in infected DCs, MHC II immunoprecipitate was probed with both K63 and K48 ubiquitin linkage-specific antibodies. Infected DCs showed ∼2-fold increase in K63-linked polyubiquitination compared to control. However, unlike K63-linked ubiquitination, there was no change in K48-linked ubiquitination ( Fig. 3A-C ; Fig. S2A and B, Supporting Information). Immunofluorescence analysis also showed colocalisation of MHC II and K63-linked ubiquitination (Fig. 3D) . These results emphasise the role of intracellular trafficking in Salmonella-mediated MHC II downregulation. MHC II trafficking is a dynamic process where intracellular MHC II is trafficked to the cell surface and surface MHC II is constantly internalised and either degraded or recycled back to the surface (van Niel et al. 2006) . Therefore, we next addressed the role of K63-linked ubiquitination in internalisation of MHC II. The surface MHC II was labelled with anti-MHC II antibody at 4 • C followed by chase at 37
• C. Staining of MHC II-antibody complex and K63 ubiquitin in the presence of saponin provided us insight into the ubiquitination status of the surface and internalised MHC II. Indeed, infected DCs showed more internalisation of MHC II-antibody complexes compared to control and internalised MHC II more strongly colocalised with K63 linkagespecific ubiquitin antibody in infected cells compared to control ( Fig. 3E and F) . K63-linked ubiquitination of MHC II, therefore, plays a key role in MHC II internalisation and degradation.
Endosomal proteolysis is responsible for
Salmonella-mediated total MHC II downregulation
In order to delineate the ubiquitinated MHC II degradation pathway, cells were subjected to either proteasomal inhibitor MG132 or endosomal acidification inhibitor (bafilomycin, folimycin and chloroquine). MG132 treatment did not rescue Salmonellamediated downregulation, thus ruling out the involvement of proteasomal degradation. In contrast, treatment with endosomal acidification inhibitor rescued MHC II levels significantly, indicating the role of endosomal degradation ( Fig. 4A and B) . For endosomal degradation of MHC II, the most likely candidate is endosomal proteolysis. To test whether endosomal protease is essential for Salmonella-mediated abrogation of MHC II, we have treated the infected cells with leupeptin hemisulfate, a serine/cysteine protease inhibitor. Indeed, leupeptin treatment rescued MHC II levels in infected cells ( Fig. 4C and D) . These data confirm the role of endosomal proteases in MHC II downregulation during Salmonella infection.
In silico analysis using PROSPER further confirms the presence of cathepsin K (cysteine protease) and cathepsin G (serine protease) cleavage site on MHC II. Previously, the ability of cathepsin G to degrade MHC II in vitro has been reported ( Fig. 4E) (Burster et al. 2010) .
Role of endosomal acidification on MHC II downregulation
To prevent their deleterious effect, endosomal proteases are synthesised as zymogens. An inhibitory motif blocks the zymogen's active site. Low pH causes release of the active site, which is either followed by inhibitory motif's autodigestion or cleavage by other active endoproteases. Although activation of endosomal proteases requires low pH, most of these proteases are functional over a broad pH range (Chapman 2006; Turk et al. 2012) . The fact that endosomal acidification inhibitors could rescue MHC II levels highlights the role of pH in endosomal proteolysis of MHC II. To confirm this, we examined the acidification status of endosomes using lysotracker DND-26 dye. Intriguingly, at an early time point (30 min), the pH of endosomes was more acidic in infected DCs compared to control ( Fig. 5A and B) . However, this difference in pH was not observed at a later time point (Fig. 5C ). This result also supports our hypothesis that lower pH is a requirement for activation of zymogens rather than for their function. Similarly, at an early time point (30 min), pH rodo conjugated bacteria also showed low pH in SCV, a modified phagosome, compared to pH in phagosome containing PFA-fixed bacteria ( Fig. 5D and E; Fig S4A, Supporting Information) . In addition, we have labelled ovalbumin with pH rodo to analyse the endosomal pH. Ovalbumin-pH rodo complex once internalised will enter endosomal trafficking pathway, and the pH rodo fluorescence indicates the acidification status of the endosomes. Our results suggest that STM-infected cells have more acidic pH than that of uninfected and PFA STM-treated cells ( Fig. 5F and G). All these lines of evidence confirm the role of phagosomal and endosomal pH in endosomal proteolysis and subversion of antigen presentation.
Delay in NOX2 recruitment is crucial for MHC II downregulation
DC phagosomes recruit NADPH oxidase 2 (NOX2) to their membranes, which in turn makes the phagosomes less acidic compared to macrophage phagosomes. Once recruited, NOX2 generates superoxide ions, which are converted to hydrogen peroxide by the enzyme, superoxide dismutase. During this process, H + ions present in the phagosomal lumen are consumed, driving an increase in pH (Savina et al. 2006) . Immunofluorescence microscopy of DCs showed delayed recruitment of NOX2 to SCV compared to phagosomes containing PFA-fixed bacteria (Fig. 6A-C) . Estimation of intracellular ROS also showed decreased levels in Salmonella-infected cells compared to fixed bacteria-treated cells at 30 min post infection ( Fig. 6D and E) . If a delay in NOX2 recruitment is essential for lowering of pH and hence for protease activation, then NOX2 null DCs treated with PFA-fixed bacteria should also show a reduction in total MHC II levels. Indeed, BMDCs derived from gp91phox −/− (NOX2 KO) mice showed decreased total MHC II levels even in PFA-fixed bacteria-treated samples, thus confirming the role of NOX2 in Salmonella-mediated MHC II downregulation. This is further supported by the fact that chloroquine treatment can rescue MHC II expression, even in gp91phox knockout mice ( Fig. 6F and G) . In accordance with this, endosomes of Gp91phox −/− DCs treated with fixed bacteria showed more acidic pH compared to wild-type DC ( Fig. 6H  and I ). In order to confirm the role of temporal ROS regulation in MHC II degradation, we treated the cells with 0.1 μM H 2 O 2 for 1 h post infection. Indeed, this resulted in the rescue of total MHC II levels in infected cells (Fig. S4B, Supporting Information) . Collectively, these results suggest that Salmonella-mediated temporal regulation of intra-endosomal ROS is a crucial strategy for evasion of antigen presentation.
Salmonella Typhimurium-infected DCs show downregulation of MHC II in vivo
To determine whether similar to ex vivo experiments S. Typhimurium infection can contribute to downregulation of MHC II in vivo, C57BL/6 mice were challenged with 10 7 CFU bacteria or PBS. CD11c-positive DCs from infected mice spleen showed a significant reduction in total MHC II as compared to splenic DCs from control mice ( Fig. 7A and B) . However, this decrease in MHC II expression was a global effect as uninfected DCs isolated from Salmonella-infected mice also express reduced levels of total MHC II. Immunohistochemistry of spleen cryosections with anti-CD11c and anti-MHC II and anti-Salmonella antibody also substantiate the decrease in total MHC II expression in DCs in the infected spleen compared to control (Fig. 7C) . Both S. Typhimurium and S. Typhi are human pathogens. However, only S. Typhi can cause systemic infection in humans; S. Typhimurium causes self-limiting diarrhoea. Salmonella Typhi infection downregulates MHC II expression in human DCs more efficiently than S. Typhimurium ( Fig. 7D and E ). This suggests that host specificity might be due to the differential ability to regulate antigen presentation by S. Typhi and S. Typhimurium in human and mice DCs.
Computational modelling of the MHC II trafficking pathway
To identify the strategy used by Salmonella to downregulate total MHC II, we developed a mathematical model of MHC II synthesis, trafficking and degradation in DCs (Fig. 8A) . A detailed description of the model is provided in supplementary information (Mathematical model supplementary method, model construction). Every parameter in the model was estimated using datasets from the literature, thus making the model consistent with available data on the MHC II trafficking pathway in DCs. Using the model, we simulated the effect of Salmonella infection by perturbing the rates of the individual steps in the pathway one at a time to different extents (1.1-fold, 2-fold and 10-fold) in such a way that antigen presentation by peptideloaded MHC II molecules is compromised. We studied the effect of these perturbations on the total MHC II pool by comparing MHC II levels in infected and uninfected DCs. Model predictions suggested that only downregulation of MHC-II synthesis, upregulation of MARCH1 expression and/or ubiquitination rate have a significant impact on the total MHC II levels both at steady state ( Fig. 8B) and transiently following the perturbation ( Fig. 8C-E 
DISCUSSION
Our study establishes a novel link between endosomal proteolysis of MHC II and delayed NOX2 recruitment to phagosomes in infected BMDCs. Salmonella Typhimurium suppresses MHC II presentation by BMDCs as an evasion strategy to subvert host adaptive immune responses. Reduction in surface and total MHC II is the reason for impaired antigen presentation in infected DCs. We and previous study has demonstrate that enhanced MHC II degradation is the primary reason for the reduction of MHC II levels. In murine DCs, MARCH1 is the major E3 ubiquitin ligase involved in MHC II ubiquitination . In this study, we have observed that Salmonella infection induces MARCH1 expression in infected DCs. This result is corroborated by the fact that infected DCs show higher MHC II ubiquitination as compared to control. Previously, McCormick, Martina and Bonifacino (2005) demonstrated that the major pool of newly synthesised MHC II is trafficked via the cell surface to the endosomal system. MHC II β chain lysine 225 polyubiquitination provides the signal for its internalisation and degradation (Shin et al. 2006; van Niel et al. 2006; Balce et al. 2011 (Fujita et al. 2013) , immune cells mainly express MARCH1. Previous studies have also demonstrated that MARCH1 is the designated ubiquitin E3 ligase involved in ubiquitination of MHC II in DCs (De Gassart et al. 2008; Oh et al. 2013; ten Broeke, Wubbolts and Stoorvogel 2013) as MARCH8-deficient mice show no change in MHC II levels in DCs and B cells (Oh and Shin 2015) . The difference between our findings from Bayer-Santos et al might be due to the fact that Mel Juso cell line does not express MARCH1.
Our results also indicate towards involvement of IL-10 in regulation of MARCH1 during Salmonella infection. However further investigation is required to elucidate the mechanism involved. The most likely explanation for this is the involvement of effector proteins secreted by Salmonella T3SS. This is also supported by the fact that the suppression of antigen presentation by Salmonella is an SPI2-dependent process. SPI-2 mutants like steD (Bayer-Santos et al. 2016) and ssaV are impaired in suppressing antigen presentation (Cheminay, Mohlenbrink and Hensel 2005; Halici et al. 2008; Lapaque et al. 2009; BayerSantos et al. 2016) . It would be interesting to investigate the ability of Salmonella to alter the cellular localisation of MARCH1 and the probable role of steD in IL-10-mediated MARCH1 regulation. Apart from the upregulation of MARCH1, Salmonella infection might regulate host deubiquitinase function, thus resulting in increased ubiquitination of MHC II. The process of internalisation of ubiquitinated MHC II from the surface requires further attention. Previous reports suggest that clathrin and AP-2 are involved in the internalisation of ubiquitinated MHC II (McCormick, Martina and Bonifacino 2005; Walseng, Bakke and Roche 2008) . However, the probability of differential trafficking of MHC II polyubiquitin containing endosome in infected cells cannot be ignored. Identification of endosomal proteases involved in MHC II degradation also needs further attention. In the future, this might help in therapeutics, as specific inhibitors of these proteases could be used to boost the immune system along with an antibiotic regime. In addition, previous studies have alluded to the preferential ubiquitination of peptide-MHC II complexes by MARCH1 (Furuta, Walseng and Roche 2013) . As our study does not differentiate the degradation of peptide MHC II complex vs MHC II-invariant chain complex, it will be interesting to investigate whether Salmonella infection reduces their levels differently. Apart from its active role in infected cells, Salmonella infection might orchestrate reduction of MHC II in uninfected cells via 
